The role of the Airn/insulin-like growth factor signalling pathway in cardiac hypertrophy, and whether this pathway is a drug target for puerarin in the treatment of cardiac hypertrophy needs to be further studied. The gene discussed is AIRN; the disease is cardiac hypertrophy.